TREA

98044695 - TESCENDO

Follow

Information

  • Trademark
  • 98044695
  • Serial Number
    98044695
  • Filing Date
    June 15, 2023
    2 years ago
  • Transaction Date
    July 22, 2025
    2 months ago
  • Status Date
    July 21, 2025
    2 months ago
  • Published for Opposition Date
    November 05, 2024
    11 months ago
  • Location Date
    December 17, 2024
    10 months ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    GILLES, DEBORAH
  • Attorney Name
    A. Reagan Fibbe
    Law Office Assigned Location Code
    M10
  • Owners
Information
Mark Drawing Code
4
Mark Identification
TESCENDO
Case File Statements
  • GS0401: Custom manufacturing of pharmaceuticals; providing technical information in the field of pharmaceutical manufacturing; manufacturing of cell therapy platforms for others
  • GS0051: Cells for medical or clinical use; pharmaceutical preparations and therapeutic agents for the treatment of cancer, infectious diseases, autoimmune and inflammatory conditions, and genetic diseases and non-genetic endocrine diseases, degenerative diseases, and aging disorders; therapeutic kits comprised of biological and pharmaceutical preparations for use in treatment and therapy for cancer, infectious diseases, autoimmune and inflammatory conditions, and genetic diseases and non-genetic endocrine diseases, degenerative diseases, and aging disorders; test kits for diagnostic preparations for medical purposes comprised of medical diagnostic reagents and assays for testing of body fluids and also containing a sample preparation device for medical diagnostic uses; T-cell receptors expressed on the cell for use in connection with diagnosing and treating cancer, infectious diseases, autoimmune and inflammatory conditions, and genetic diseases and non-genetic endocrine diseases, degenerative diseases, and aging disorders; diagnostic reagents for medical clinical use for treatment of cancer; cell culture kits for medical use primarily comprised of imaging and detection agents for diagnosing and monitoring cancer, and also containing a diagnostic apparatus for medical purposes used in medical laboratories for testing cancer cells; medical testing and treatment product kits primarily comprised of cells for diagnosing and treating cancer, infectious diseases, autoimmune and inflammatory conditions, and genetic diseases and non-genetic endocrine diseases, degenerative diseases, and aging disorders
  • GS0011: Reagents for scientific and research purposes, drug discovery research and scientific development, and biological and pharmaceutical reagents, for scientific and research purposes, for use in the manufacturing process of cell therapy platforms; diagnostic reagents for scientific clinical use for treatment of cancer
  • GS0441: Medical services; medical services, namely, cellular immunotherapy treatments; medical services, namely, human cancer treatment; providing medical information relating to immunotherapy; providing cancer therapy advice and consultancy
  • GS0421: Medical and scientific research services; medical laboratory services; providing information on medical and scientific research in the field of oncology; compiling and analyzing data for research purposes in the field of oncology; consulting in the field of medical and scientific research
Case File Event Statements
  • 6/19/2023 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 7/19/2023 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/31/2024 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/7/2024 - a year ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/7/2024 - a year ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/7/2024 - a year ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/7/2024 - a year ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/7/2024 - a year ago
    9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/3/2024 - a year ago
    8 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 5/3/2024 - a year ago
    7 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 8/7/2024 - a year ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/15/2024 - a year ago
    14 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 9/15/2024 - a year ago
    15 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 9/15/2024 - a year ago
    13 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 9/15/2024 - a year ago
    12 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 9/24/2024 - a year ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/16/2024 - a year ago
    17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/5/2024 - 11 months ago
    18 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/5/2024 - 11 months ago
    19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 12/17/2024 - 10 months ago
    20 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 7/21/2025 - 2 months ago
    21 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 7/21/2025 - 2 months ago
    22 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6